Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Erie, Pennsylvania 16501


Purpose:

The objective of this study is to evaluate the safety and effectiveness of Zylet in comparison with Lotemax, Tobramycin and the vehicle of Zylet for the treatment of blepharoconjunctivitis in pediatric subjects.


Criteria:

Inclusion Criteria: - children 0-6 years of age. - clinical diagnosis of blepharoconjunctivitis - Parent/guardian must understand, be willing and able to comply with all treatment and follow-up procedures. - Parent/guardian must understand, be willing and able to provide informed consent and Health Insurance Portability Accountability Act (HIPAA) authorization. Exclusion Criteria: - Known hypersensitivity to corticosteroids, aminoglycosides, or any component of the study medication. - Subjects who have a history of ocular surgery, including laser procedures, within the past 6 months. - Subjects who are monocular. - Subjects who have a history of any severe/serious ocular pathology or medical condition that could result in the subject's inability to complete the study. - Subjects who have participated in an ophthalmic drug or device research study within 30 days prior to entry in this study.


NCT ID:

NCT00705159


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Erie, Pennsylvania 16501
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.